M. Wright

发表

Chimeric Antigen Receptor Therapy as a Means of Cellular Immunotherapy in B Cell Malignancies

O. Oluwole, M. Wright, 2017 .

Incidence and Survival for Common Cancers Are Lower in New Mexico and Along the US-Mexico Border Than Elsewhere in the United States

C. Gard, Anup Amatya, Anup K Amatya, 2020, Cureus.

Characterization of a messenger RNA polynucleotide vaccine vector.

D. Curiel, R. Benjamin, A. Lobuglio, 1995, Cancer research.

A Sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo.

D. Curiel, A. Lobuglio, M. J. Pike, 1995, Nucleic acids research.

Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy.

D. Curiel, M. Wang, R. Alvarez, 1997, Gynecologic oncology.

An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2

M. Kim, J. Grim, G. Siegal, 1997, Gene Therapy.

Gene therapy strategies for carcinoma of the breast

D. Curiel, J. Ruppert, G. Bilbao, 1997, Breast Cancer Research and Treatment.

The status of surgery in the management of high-risk prostate cancer

D. Gillatt, C. Bach, E. Rowe, 2014, Nature Reviews Urology.

Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment.

Mark Wright, Daniela De Angelis, William L Irving, 2006, Journal of clinical epidemiology.

A novel gene therapy strategy for elimination of prostate carcinoma cells from human bone marrow.

R. Hockett, D. Curiel, M. Kim, 1997, Human gene therapy.